165
Participants
Start Date
July 3, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
ELIXCYTE
ELIXCYTE, a new investigational product developed by UnicoCell Biomed, contains allogenic Adipose-derived stem cells (ADSCs). The ADSCs of ELIXCYTE for subjects were obtained from donors, and the Sponsor followed the manufacturing and testing procedures described in chemistry, manufacturing and control (CMC) information in order to assure the quality of final products.
Saline
Placebo control used in the study.
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
Chang Gung Memorial Hospital, Linkou, Taoyuan District
RECRUITING
Taipei Medical University Shuang-Ho Hospital, New Taipei City
RECRUITING
National Taiwan University Hospital, Taipei
UnicoCell Biomed CO. LTD
INDUSTRY